Table I.
Baseline SUVs prior to treatment.
| Region (10 cm3 VOI) | Mean ± SD | CI (95%) | Normal distribution (P-value) |
|---|---|---|---|
| Aortic arch SUVmax | 1.66±0.37 | 1.55–1.76 | 0.66 |
| Aortic arch SUVmean | 1.18±0.26 | 1.10–1.25 | 0.66 |
| Liver SUVmax | 2.13±0.50 | 1.99–2.27 | 0.16 |
| Liver SUVmean | 1.58±0.34 | 1.49–1.68 | 0.62 |
| Spleen SUVmax | 1.83±0.48 | 1.70–1.97 | 0.07 |
| Spleen SUVmean | 1.35±0.36 | 1.25–1.45 | 0.33 |
N=51. P<0.05 was considered to indicate a statistically significant result. Data were tested for normal distribution using the D’Agostino-Pearson omnibus test. SUV, standardized uptake value; SD, standard deviation; CI, confidence interval; VOI, volume of interest.